Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Intracept Procedure developed by Relievant Medsystems has demonstrated safety and effectiveness in multiple Level I randomized controlled trials for the treatment of chronic vertebrogenic low back pain. Clinical data show durable improvements in pain and function, with results validated across independent systematic reviews and real-world practice[2][1].
The Intracept Procedure remains the only FDA-cleared therapy specifically targeting vertebrogenic pain[7].
Physicians trained on this procedure are seeing similar life-changing results in their practices[2].
Four independent systematic reviews have validated its effectiveness as a treatment for vertebrogenic low back pain[2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Relievant Medsystems.